Duopharma Biotech (Malaysia) Probability of Future Stock Price Finishing Over 6.22

7148 Stock   1.26  0.01  0.80%   
Duopharma Biotech's future price is the expected price of Duopharma Biotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Duopharma Biotech Bhd performance during a given time horizon utilizing its historical volatility. Check out Duopharma Biotech Backtesting, Duopharma Biotech Valuation, Duopharma Biotech Correlation, Duopharma Biotech Hype Analysis, Duopharma Biotech Volatility, Duopharma Biotech History as well as Duopharma Biotech Performance.
  
Please specify Duopharma Biotech's target price for which you would like Duopharma Biotech odds to be computed.

Duopharma Biotech Target Price Odds to finish over 6.22

The tendency of Duopharma Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over  6.22  or more in 90 days
 1.26 90 days 6.22 
close to zero percent
Based on a normal probability distribution, the odds of Duopharma Biotech to move over  6.22  or more in 90 days from now is close to zero percent (This Duopharma Biotech Bhd probability density function shows the probability of Duopharma Stock to fall within a particular range of prices over 90 days) . Probability of Duopharma Biotech Bhd price to stay between its current price of  1.26  and  6.22  at the end of the 90-day period is about 60.65 .
Assuming the 90 days trading horizon Duopharma Biotech Bhd has a beta of -0.13. This suggests as returns on the benchmark increase, returns on holding Duopharma Biotech are expected to decrease at a much lower rate. During a bear market, however, Duopharma Biotech Bhd is likely to outperform the market. Additionally Duopharma Biotech Bhd has an alpha of 0.0542, implying that it can generate a 0.0542 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Duopharma Biotech Price Density   
       Price  

Predictive Modules for Duopharma Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Duopharma Biotech Bhd. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.061.262.94
Details
Intrinsic
Valuation
LowRealHigh
0.051.072.75
Details

Duopharma Biotech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Duopharma Biotech is not an exception. The market had few large corrections towards the Duopharma Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Duopharma Biotech Bhd, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Duopharma Biotech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.05
β
Beta against Dow Jones-0.13
σ
Overall volatility
0.07
Ir
Information ratio -0.05

Duopharma Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Duopharma Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Duopharma Biotech Bhd can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Duopharma Biotech may become a speculative penny stock

Duopharma Biotech Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Duopharma Stock often depends not only on the future outlook of the current and potential Duopharma Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Duopharma Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding928.3 M
Cash And Short Term Investments138 M

Duopharma Biotech Technical Analysis

Duopharma Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Duopharma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Duopharma Biotech Bhd. In general, you should focus on analyzing Duopharma Stock price patterns and their correlations with different microeconomic environments and drivers.

Duopharma Biotech Predictive Forecast Models

Duopharma Biotech's time-series forecasting models is one of many Duopharma Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Duopharma Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Duopharma Biotech Bhd

Checking the ongoing alerts about Duopharma Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Duopharma Biotech Bhd help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Duopharma Biotech may become a speculative penny stock

Other Information on Investing in Duopharma Stock

Duopharma Biotech financial ratios help investors to determine whether Duopharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Duopharma with respect to the benefits of owning Duopharma Biotech security.